Key Takeaways
- Caterpillar (CAT) delivered a record-breaking quarter, reporting its first-ever revenue exceeding $20 billion and crushing earnings estimates behind a surge in AI data center demand.
- Pfizer (PFE) raised its full-year revenue guidance midpoint to $61.5 billion, supported by an 18% operational growth in its non-COVID product portfolio.
- BioNTech (BNTX) slashed its 2026 revenue forecast by approximately 20% to a range of €1.6B–€1.9B, citing sharply declining demand for COVID-19 vaccines.
- McDonald’s (MCD) appointed Skye Anderson as President of its USA Division following a quarter of modest 0.8% domestic comparable sales growth.
- Geopolitical Tensions: Ukrainian drone strikes targeted multiple Wildberries warehouses across Russia overnight, resulting in at least five fatalities and significant logistics damage.
Industrial and Infrastructure Strength
Caterpillar (CAT) shares surged in premarket trading after the company reported adjusted EPS of $8.17, far exceeding the $6.17 analyst estimate. The industrial giant benefited from a massive buildout of AI data centers, which drove a 17% revenue increase in its Power & Energy segment. The company's order backlog grew by $9.4 billion in the second quarter alone, reaching a record $72.1 billion, prompting management to raise full-year sales growth expectations to the mid-to-high teens.
Pharmaceutical Divergence
Pfizer (PFE) reported second-quarter revenue of $15.03 billion, beating estimates of $14.41 billion. While the company lowered its COVID-19 product revenue expectations to $4 billion, strong performance from products like Eliquis (up to $2.43 billion) allowed it to raise its overall revenue guidance. Pfizer also announced an expansion of its productivity initiatives, now targeting a total of $6.7 billion in net cost savings.
In contrast, BioNTech (BNTX) faced a challenging quarter, reporting a revenue miss at €105.6 million against estimates of €153.9 million. The company is undergoing a significant leadership transition, with Guido Oelkers named as the incoming CEO to oversee a pivot toward oncology. BioNTech's revised guidance reflects a shift in the timing of milestone payments and a continued drawdown of existing vaccine inventory in the European market.
Consumer and Retail Developments
McDonald’s (MCD) reported a slight beat on adjusted EPS at $3.38, though global comparable sales growth of 1.3% was softer than the 1.39% expected. The company is looking to revitalize its largest market by naming Skye Anderson as President of the USA Division. Anderson, a 26-year veteran of the company, previously served as COO of the U.S. business and is tasked with accelerating performance as domestic guest counts face pressure.
On the international front, the retail sector saw significant disruption as Ukrainian drones struck warehouses belonging to Wildberries, Russia's largest online retailer. The strikes hit facilities in the Leningrad and Moscow regions, with local officials confirming at least five deaths in the city of Chekhov. The attacks are part of an intensifying campaign targeting Russian logistics infrastructure, which has reportedly wiped out a substantial portion of the e-commerce giant's storage capacity.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.